{{Rsnum
|rsid=6435862
|Gene=BARD1
|Chromosome=2
|position=214807822
|Orientation=plus
|GMAF=0.2075
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Summary=increases the odds of aggressive neuroblastoma
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=BARD1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 8.0 | 44.6 | 47.3
| HCB | 3.6 | 16.1 | 80.3
| JPT | 1.8 | 31.0 | 67.3
| YRI | 8.2 | 41.8 | 50.0
| ASW | 10.5 | 38.6 | 50.9
| CHB | 3.6 | 16.1 | 80.3
| CHD | 1.8 | 21.1 | 77.1
| GIH | 10.9 | 37.6 | 51.5
| LWK | 6.4 | 38.5 | 55.0
| MEX | 5.2 | 25.9 | 69.0
| MKK | 4.5 | 34.2 | 61.3
| TSI | 4.9 | 32.4 | 62.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19412175
|Title=Common variations in [[BARD1]] influence susceptibility to high-risk [[neuroblastoma]]
|OA=1
}}

Each G allele has been associated with an allelic odds ratio of 1.68 (p = 8.65 x 10(-18)) for risk of aggressive [[neuroblastoma]].

{{omim
|id=256700
|desc=NEUROBLASTOMA
|rsnum=6435862
}}

{{omim
|id=613016
|rsnum=6435862
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6435862
|overall_frequency_n=97
|overall_frequency_d=120
|overall_frequency=0.808333
|n_genomes=50
|n_genomes_annotated=0
|n_haplomes=82
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=23222812
|Title=Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}